Last reviewed · How we verify
HUMAN IMMUNOGLOBULIN G — Competitive Intelligence Brief
marketed
Human Immunoglobulin G [EPC]
Live · refreshed every 30 min
Target snapshot
HUMAN IMMUNOGLOBULIN G (HUMAN IMMUNOGLOBULIN G).
Comparator set (2 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HUMAN IMMUNOGLOBULIN G TARGET | HUMAN IMMUNOGLOBULIN G | marketed | Human Immunoglobulin G [EPC] | 2006-01-01 | ||
| Botulinum neurotoxin | Botulinum neurotoxin | University of Miami | marketed | Human Immunoglobulin G [EPC] | ||
| Human immunoglobulin | Human immunoglobulin | Centre Hospitalier St Anne | marketed | Human Immunoglobulin G [EPC] |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Human Immunoglobulin G [EPC] class)
- · 1 drug in this class
- Centre Hospitalier St Anne · 1 drug in this class
- University of Miami · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HUMAN IMMUNOGLOBULIN G CI watch — RSS
- HUMAN IMMUNOGLOBULIN G CI watch — Atom
- HUMAN IMMUNOGLOBULIN G CI watch — JSON
- HUMAN IMMUNOGLOBULIN G alone — RSS
- Whole Human Immunoglobulin G [EPC] class — RSS
Cite this brief
Drug Landscape (2026). HUMAN IMMUNOGLOBULIN G — Competitive Intelligence Brief. https://druglandscape.com/ci/human-immunoglobulin-g. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab